Abstract:Purpose To synthesize the dimer of GX1 and identify whether its affinity and targeting are better than those of GX1. To prepare Ga-68-DOTA-KEK-(GX1)(2) and to apply it to PET and Cerenkov imaging of gastric cancer.</p> Methods Ga-68-DOTA-KEK-(GX1)(2) was prepared, and the labeling yield and stability were determined. Its specificity and affinity were verified using an in vitro cell binding assay and competitive inhibition test, cell immunofluorescence, and cell uptake and efflux study. Its tumor-targeting ability was determined by nano PET/CT and Cerenkov imaging, standardized uptake value (SUV), signal-to-background ratio (SBR) quantification, and a biodistribution study in tumor-bearing nude mice.</p> Results Ga-68-DOTA-KEK-(GX1)(2) was successfully prepared, and the labeling yield was more than 97%. It existed stably for 90 min in serum. The binding of Ga-68-DOTA-KEK-(GX1)(2) to cocultured HUVECs (Co-HUVECs) was higher than that to human umbilical vein endothelial cells (HUVECs), BGC823 cells, and GES cells. It was also higher than that of Ga-68-DOTA-GX1, indicating that the dimer did improve the specificity and affinity of GX1. The binding of KEK-(GX1)(2) to Co-HUVECs was significantly higher than that of GX1. Additionally, the uptake of Ga-68-DOTA-KEK-(GX1)(2) by Co-HUVECs was higher than that of Ga-68-DOTA-GX1 and reached a maximum at 60 min. Nano PET/CT and Cerenkov imaging showed that the tumor imaging of the nude mice injected with Ga-68-DOTA-KEK-(GX1)(2) was clear, and the SUV and SBR value of the tumor sites were significantly higher than those of the nude mice injected with Ga-68-DOTA-GX1, indicating that the probe had better targeting in vivo. Finally, the biodistribution showed quantitatively that when organs such as the kidney and liver metabolized rapidly, the radioactivity of the tumor site of the nude mice injected with Ga-68-DOTA-KEK-(GX1)(2) decreased relatively slowly. At the same time, the percentage of injected dose per gram (%ID/g) of the tumor site was higher than that of other normal organs except the liver and kidney at 60 min, which indicated that the tumor had good absorption of the probe.</p> Conclusion GX1 was modified successfully, and the in vivo and in vitro properties of the GX1 dimer were significantly better than those of GX1. The imaging probe, Ga-68-DOTA-KEK-(GX1)(2), was successfully prepared, which provides a candidate probe for PET and Cerenkov diagnosis of gastric cancer.</p>

Radio-Labeling and Micro-Pet Study of Cu-64 Labeled D-Glucose for Tumor Imaging

Radio-synthesis, Quality Control and Micro-PET Imaging of Cu-64-DOTA-TATE

<SUP>68</SUP>Ga-Labeled GX1 Dimer: A Novel Probe for PET/Cerenkov Imaging Targeting Gastric Cancer

Synthesis and Evaluation of (68)Ga-Labeled DOTA-2-deoxy-D-glucosamine As a Potential Radiotracer in Μpet Imaging.

Synthesis and Evaluation of New Nuclides Ga-68 Labeled D-Glucose for Potential PET Imaging Agent

Radiolabeling and Evaluation of (64)Cu-Dota-f56 Peptide Targeting Vascular Endothelial Growth Factor Receptor 1 in the Molecular Imaging of Gastric Cancer.

Synthesis and Biodistribution of A New 99Mtc-Oxo Complex with Deoxyglucose Dithiocarbamate for Tumor Imaging

99Tcmn-Dgdtc,a New Glucose Metabolic Agent,the Pharmacokinetics and Imaging Results

Synthesis and Biological Evaluation of (68) Ga-labeled Pteroyl-Lys Conjugates for Folate Receptor-Targeted Tumor Imaging.

Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA

Improving Tumor Uptake and Pharmacokinetics of (64)Cu-Labeled Cyclic RGD Peptide Dimers with Gly(3) and PEG(4) Linkers.

68Ga/177lu-Labeled DOTA-TATE Shows Similar Imaging and Biodistribution in Neuroendocrine Tumor Model

Synthesis and evaluation of 111 In-labeled d -glucose as a potential SPECT imaging agent

Design and Bio.Evaluation of Cu-64-Nota-Herceptin for Tumor Targeted Micro-Pet Imaging

64 Cu-Labeled Boron-Containing Cyclic RGD Peptides for BNCT and PET Imaging

Synthesis and evaluation of 64 Cu-radiolabeled NOTA-cetuximab ( 64 Cu-NOTA-C225) for immuno-PET imaging of EGFR expression.

Design and Radio-Synthesis of Somatostatin Receptors Targeted 68 Ga-DOTA-Benereotide for Non-Invasive PET Imaging

Small-Animal PET of Tumor Damage Induced by Photothermal Ablation with 64Cu-Bis-dota-hypericin

Pilot Study of 64cu(i) for PET Imaging of Melanoma

Synthesis and Evaluation Of111in-Dota-mab109 Monoclonal Antibody for Potential SPECT Molecular Imaging

Quality Control, Metabolism Analysis And Micro-Pet Imaging Of Cu-64-Nota-Trastuzumab In Gastric Cancer Patient-Derived Xenograft Mouse Model